About Sensorium Therapeutics
Sensorium Therapeutics is a private company based in Medford, Massachusetts, incorporated in 2021 in Delaware. It has reported $60,453,009 raised in three offerings on Form D since July 2021.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Jan 28, 2025 | Feb 12, 2025amended Jul 15, 2025 | $26,763,207of $58.4M target | 19 | $1.4M | Equity, OptionsRule 506(b) | Form D/A ↗1 earlier filing |
| Sep 19, 2022 | Oct 4, 2022amended Dec 6, 2023 | $24,689,802of $24.7M target | 64 | $385K | EquityRule 506(b) | Form D/A ↗1 earlier filing |
| Jul 8, 2021 | Jul 23, 2021 | $9,000,000fully sold | 47 | $191K | Equity, DebtRule 506(b) | Form D ↗ |
| Total, three offerings | $60,453,009 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Sensorium Therapeutics's Form D filed Jul 15, 2025.
JR
Jerrold Rosenbaum
Director
RK
Ryan Katz
Director
KL
Kevin Lalande
Director
RS
Richard Simon
Director
BG
Balkrishan Gill
Director
AG
Alexandra Glucksmann
Director
JH
Jacob Hooker
Executive officer and director
Earlier filings also listed Pranav Tadi (vp, head of finance, last listed Dec 2023).